Public Profile

Hospira

Hospira, Inc., a leading global provider of injectable drugs and infusion technologies, is headquartered in the United States. Founded in 2004, the company has established itself as a key player in the pharmaceutical and biotechnology industry, focusing on critical care and hospital products. With major operational regions across North America, Europe, and Asia, Hospira is renowned for its commitment to quality and innovation. The company offers a diverse range of core products, including sterile injectable medications, biosimilars, and advanced infusion systems, which are distinguished by their reliability and safety features. Hospira's market position is bolstered by its notable achievements in enhancing patient care and streamlining hospital operations, making it a trusted partner in healthcare settings worldwide.

DitchCarbon Score

How does Hospira's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Hospira's score of 41 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Hospira's reported carbon emissions

Hospira, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Hospira may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. As such, it will be important for Hospira to establish clear climate goals and transparency in emissions reporting to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hospira's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hospira is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hospira is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Baxter

US
Health and social work services (85)
Updated 1 day ago

Auro Medics Pharma Llc

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Salix Pharmaceuticals Ltd.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Sagent Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Sandoz

CH
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Perrigo

IE
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers